decoration

Poids de l’Open access dans la production CNRS

Titre
Consolidation anti-CD22 fractionated radioimmunotherapy with Y-90-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial
BSO - Titre
Consolidation anti-CD22 fractionated radioimmunotherapy with 90Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial
DOI
DOAI
Identifiant WoS
WOS:000397187600011
Accès ouvert
OA - Non
Source - Accès ouvert
OA - Non
Type d'accès
Non OA
Editeur

Elsevier

Source

LANCET HAEMATOLOGY

ISSN
2352-3026
Type de document
  • Article
Notoriété
5 - Exceptionnelle
CNRS
Oui
CNRS - Institut
  • INSB - Institut des sciences biologiques
uid:/RNKDWXTJ
Powered by Lodex 9.6.0
decoration